Trial Profile
Investigation of combined phosphodiesterase 5 inhibitor and isosorbide mononitrate for the treatment of resistant hypertension
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Jul 2020
Price :
$35
*
At a glance
- Drugs Isosorbide mononitrate (Primary) ; Sildenafil (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- 30 Oct 2005 New trial record.